Avascular necrosis (AVN) is a condition where bone tissue dies because it loses its blood supply. For most people, the cause is trauma, steroid use, or excessive alcohol consumption, not genetics. However, in a small number of cases, specific inherited conditions can predispose someone to developing AVN, making the question of heredity relevant for a minority of patients.
What Exactly Is Avascular Necrosis?
Avascular necrosis, also called osteonecrosis, happens when blood flow to a bone is interrupted. Without blood, the bone tissue begins to die and can eventually collapse. The condition most often affects the hip, but it can also occur in the knee, shoulder, and ankle.
Bone is living tissue. It constantly breaks down and rebuilds itself. When the blood supply stops, this process halts. The bone becomes weak, develops tiny fractures, and may ultimately flatten or collapse. Once a bone collapses, arthritis often follows, and joint replacement may become necessary.
Is Avascular Necrosis Hereditary?
The direct answer is no for the vast majority of cases. Avascular necrosis is not typically passed down from parent to child as a single inherited condition. The most common causes are physical injury, long-term corticosteroid use, and heavy alcohol consumption.
That said, certain rare genetic disorders do increase a person’s risk of developing AVN. These conditions are inherited, but they do not cause AVN directly. Instead, they create the circumstances — such as abnormal blood clotting or bone metabolism problems — that make AVN more likely to occur.
What Are the Non-Hereditary Causes of AVN?
Understanding the common causes helps clarify why genetics usually play no role. Trauma is the leading cause. A broken bone or dislocated joint can tear the blood vessels that feed the bone.
Steroid use is the second most common cause. High doses of corticosteroids, often used to treat autoimmune diseases like lupus or rheumatoid arthritis, can interfere with the body’s ability to break down fats. These fats can accumulate in blood vessels and block the small arteries that supply bone.
Alcohol is another major risk factor. Heavy drinking over several years can cause fatty deposits to build up in blood vessels, similar to the mechanism seen with steroids. The exact threshold varies, but chronic heavy use significantly increases risk.
Other causes include:
- Radiation therapy for cancer
- Pancreatitis
- Gaucher disease
- Sickle cell disease
- Decompression sickness (diver’s disease)
None of these are inherited in the typical sense, though some — like sickle cell disease and Gaucher disease — do have a genetic component.
When Could Genetics Play a Role?
There are inherited conditions that make AVN more likely. These are the exceptions to the rule. If you have a family history of AVN without any of the typical risk factors, a genetic cause may be worth investigating.
Thrombophilia is one such condition. It is a tendency to form blood clots more easily than normal. Some forms of thrombophilia are inherited. Because AVN can result from a blood clot blocking the blood supply to a bone, people with this condition face a higher risk.
Hypofibrinolysis is the opposite problem. The body does not break down blood clots effectively. This also increases the risk of blockages in the small vessels that feed bone tissue.
There are also rare genetic bone disorders that can lead to AVN. Conditions like multiple epiphyseal dysplasia or spondyloepiphyseal dysplasia affect bone growth and development. These conditions can make bones more fragile and more susceptible to collapse, which may present similarly to AVN.
Research has also identified certain gene variations that may make some people more vulnerable to steroid-induced AVN. These studies are still in early stages. They do not currently change how doctors screen or treat patients.
How Common Is Inherited AVN?
Inherited causes of AVN are rare. Most medical literature suggests that fewer than 5% of AVN cases are linked to genetic factors. The overwhelming majority of cases trace back to trauma, steroids, alcohol, or other acquired conditions.
If you have a first-degree relative — a parent, sibling, or child — with AVN, your personal risk is still very low unless you share other risk factors. Family history alone does not warrant aggressive screening.
Doctors typically consider genetic testing for AVN only when a patient has no identifiable risk factors and has a strong family history of the condition or a personal history of unexplained blood clots.
What Are the Symptoms of AVN?
AVN often produces no symptoms in its earliest stages. Many people are diagnosed only after the condition has progressed. When symptoms do appear, pain is usually the first sign.
The pain typically develops gradually and is localized to the affected joint. For hip AVN, the pain is usually felt in the groin, buttock, or thigh. Some people report pain in the knee even when the problem is in the hip.
As the condition worsens, the joint becomes stiff and difficult to move. Weight-bearing activities like walking or standing become painful. Eventually, the pain may persist even at rest.
The time from the interruption of blood supply to the onset of symptoms varies widely. It can take months or even years for the bone to weaken enough to cause noticeable pain. This delay is why early diagnosis is difficult without imaging.
How Is AVN Diagnosed?
Imaging is the primary tool for diagnosing AVN. X-rays are often the first test ordered, but they may appear normal in the early stages of the disease. This can delay diagnosis if a doctor relies on X-rays alone.
Magnetic resonance imaging (MRI) is the most sensitive test for detecting early AVN. An MRI can show changes in the bone marrow before structural damage occurs. It is the gold standard for diagnosis.
If a doctor suspects an inherited clotting disorder is behind the AVN, blood tests can check for specific genetic mutations associated with thrombophilia. These tests are not routine. They are reserved for patients with unusual presentations.
Can AVN Be Prevented?
Prevention focuses on managing the known risk factors. Limiting alcohol consumption is one of the most effective steps a person can take. Avoiding high-dose or long-term steroid use when alternatives exist also reduces risk.
For people who must take steroids for a chronic condition like asthma or autoimmune disease, the risk of AVN is a known trade-off. The benefits of the medication typically outweigh the relatively small risk of developing AVN. Doctors usually prescribe the lowest effective dose for the shortest necessary duration.
For people with inherited clotting disorders, preventive measures may include blood-thinning medication. This decision is made on an individual basis by a specialist. There is no standard protocol for preventing AVN in this population because the risk is still relatively low.
What Are the Treatment Options?
Treatment depends on the stage of the disease at diagnosis. Early-stage AVN, before the bone collapses, may be managed with nonsurgical options. These include medications for pain, physical therapy to maintain joint range of motion, and reduced weight-bearing on the affected joint.
Some patients benefit from a procedure called core decompression. In this surgery, the surgeon removes a cylinder of bone from the affected area. This reduces pressure inside the bone and creates a channel for new blood vessels to grow. The procedure is most effective in early-stage disease.
Once the bone has collapsed, surgical options become more limited. Joint replacement is the most reliable treatment for advanced AVN. Hip replacement, in particular, has excellent long-term outcomes for most patients.
No medication has been proven to reverse AVN or restore blood flow to dead bone. Some experimental treatments, like bone marrow aspirate concentrate injections, are being studied. The evidence for these is still limited, and they are not considered standard care.
What Is the Long-Term Outlook?
The outlook for AVN depends heavily on when it is caught. Early diagnosis offers the best chance of preserving the joint. Delayed diagnosis often means joint replacement is inevitable.
Without treatment, AVN typically progresses. The affected bone will continue to weaken and collapse. The timeline varies, but most untreated cases advance to significant joint damage within a few years of symptom onset.
After joint replacement surgery, most people experience significant pain relief and improved function. The majority of hip replacements last 15 to 20 years or more. Younger patients may eventually need a second replacement, but this is a manageable consideration for most people.
Frequently Asked Questions
Can avascular necrosis skip a generation?
No, AVN itself does not follow a clear inheritance pattern that would cause it to skip generations. The rare genetic conditions that increase AVN risk are inherited directly, but they do not guarantee that every carrier will develop the condition.
Should I get genetic testing if a family member has AVN?
Genetic testing is not recommended for most people with a family history of AVN. Testing is only considered when a patient has no known risk factors and a strong family history of the condition or unexplained blood clots.
Is steroid-induced avascular necrosis hereditary?
The AVN itself is not directly inherited, but some research suggests certain gene variations may make some people more vulnerable to developing AVN after steroid use. This research is early and does not currently change clinical practice.
Can avascular necrosis be passed from parent to child?
AVN is not directly passed from parent to child in most cases. Rare inherited conditions like thrombophilia or certain bone dysplasias can increase risk, but these conditions are uncommon and do not guarantee a child will develop AVN.
